Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
Goh Eun Chung, Su Jong Yu, Jeong‐Ju Yoo, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 5
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
Harry Crane, Guy D. Eslick, Cameron Gofton, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 436-448
Open Access | Times Cited: 15
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
Yuan-dong Sun, Hao Zhang, Yuanmin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189086-189086
Closed Access | Times Cited: 7
Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
Karina Sato-Espinoza, Perapa Chotiprasidhi, Mariella R. Huamán, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 3, pp. 452-464
Open Access | Times Cited: 7
Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population
Young Lee, Eun Ju Cho, Eun Kyung Choe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study
Min Kyung Park, Moon Haeng Hur, Hye‐Sung Moon, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 799-810
Closed Access | Times Cited: 6
Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017–2018
Yan Chen, Chuan Lü, Haonan Ju, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study
Zhiqin Xie, Hongxia Li, Bingkun Wang, et al.
European Journal of Internal Medicine (2023) Vol. 110, pp. 62-70
Closed Access | Times Cited: 13
Vitamin C and vitamin D3 alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
Qingling Chen, Lili Zhao, Ling Mei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Impact of non‐obese metabolic dysfunction‐associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study
Shuhei Fukunaga, Michita Mukasa, Tomoyuki Nakane, et al.
Hepatology Research (2023) Vol. 54, Iss. 2, pp. 201-212
Closed Access | Times Cited: 13
Novel Two-Stage, Contrastive Learning for Predicting the Phenotype of Metabolic Dysfunction-Associated Fatty Liver among Adults: Method Development and Evaluation (Preprint)
Sizhe Jasmine Chen, Da Xu, Derek K. Hu, et al.
(2025)
Closed Access
Mortality outcomes in diabetic metabolic dysfunction-associated fatty liver disease: non-obese versus obese individuals
Pengwei Zhang, Yijun Zeng, Sijia Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Nahúm Méndez‐Sánchez, Willem Pieter Brouwer, Frank Lammert, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 884-896
Open Access | Times Cited: 3
Associations of MAFLD subtypes and air pollutants with multi-system morbidity and all-cause mortality: A prospective cohort study
Jingyi Zhang, Shanshan Ran, Shengtao Wei, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117893-117893
Open Access
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project
Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
Sabhita Shabir Shaikh, Fakhar Ali Qazi Arisar, Saba Nafay, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 1, pp. 54-64
Open Access | Times Cited: 1
Relationship of long-term exposure to air pollutant mixture with metabolic-associated fatty liver disease and subtypes: A retrospective cohort study of the employed population of Southwest China
Chuanteng Feng, Bo Yang, Zihang Wang, et al.
Environment International (2024) Vol. 188, pp. 108734-108734
Open Access | Times Cited: 1
Letter: for improved prognostic value, use MAFLD
Harry Crane, Guy D. Eslick, Jacob George
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 1, pp. 147-148
Open Access
Page 1

Scroll to top